Abstract
Although long-term stent placement via endoscopic gallbladder stenting (EGBS) reportedly reduces cholecystitis recurrence in patients unfit to undergo cholecystectomy, it can increase the frequency of other late adverse events (AEs) such as cholangitis. This study aimed to examine the feasibility of endoscopic gallbladder inside-stenting (EGB-IS) with lavage and aspiration. This prospective, single-center, pilot study enrolled 83 patients with acute calculous cholecystitis who were poor candidates for surgery. A dedicated catheter with eight side holes was used for lavage and aspiration, and a dedicated single-pigtail stent equipped with a thread was used for EGB-IS. Outcomes such as technical success, clinical success, early AEs, recurrence of cholecystitis, and other symptomatic late AEs associated with EGB-IS with lavage and aspiration were evaluated. The technical and clinical success rates were 80.7% (67/83) and 98.5% (66/67), respectively. The rate of early AEs was 3.6% (3/83). The rate of recurrent cholecystitis was 4.5% (3/66) and that of symptomatic late AEs (besides cholecystitis) was 6.1% (4/66). Consequently, the rate of overall late AEs (cholecystitis plus other events) was 10.6% (7/66). The 1-, 2-, and 3-year cumulative incidence rates of all late AEs were 3.2%, 11.2%, and 18.9%, respectively. EGB-IS with lavage and aspiration for calculous cholecystitis showed promising results in poor surgical candidates. EGB-IS may be useful when EGBS with long-term stent placement is planned, since prevention of cholecystitis recurrence, without a rise in the incidence of other AEs, is anticipated.
Similar content being viewed by others
Introduction
Calculous cholecystitis is a common disease, for which early surgical cholecystectomy is the standard treatment1. However, either percutaneous or endoscopic gallbladder drainage is indicated when emergent surgery cannot be performed in the acute phase due to the patient’s general condition2. Even in such cases, the recurrence rate is high if cholecystectomy is not performed after drainage; thus, elective surgery is recommended after improvement in infection, inflammation, and the patient’s general condition3,4,5,6,7,8. However, owing to advanced age and/or significant underlying diseases, cholecystectomy may be difficult in some cases, even in the elective setting9,10.
Endoscopic gallbladder stenting (EGBS) via endoscopic retrograde cholangioscopy does not require an external fistula tube, unlike percutaneous transhepatic gallbladder drainage (PTGBD); therefore, long-term stent placement is possible without affecting the patient’s daily life. Several studies have demonstrated that long-term stent placement via EGBS is useful for preventing the recurrence of cholecystitis11,12,13. However, studies have also shown that the frequency of other late adverse events (AEs), such as cholangitis, is elevated due to duodenobiliary reflex and bacterial contamination via the stents, especially when the period of stent placement is prolonged14. Another concern with EGBS is that the highly viscous, infected bile sometimes causes premature obstruction and insufficient drainage, unlike PTGBD.
To overcome these problems, we developed a novel method of endoscopic gallbladder inside-stenting (EGB-IS), in which the stent is placed above the duodenal papilla, combined with lavage and aspiration, to achieve better short- and long-term outcomes after EGBS. This study aimed to examine the feasibility and utility of EGB-IS with lavage and aspiration for calculous cholecystitis in poor surgical candidates.
Methods
Study design and population
This prospective, single-center, pilot study included consecutive patients with acute calculous cholecystitis who were considered poor surgical candidates and scheduled to undergo EGB-IS with lavage and aspiration. The study period extended from July 2017 to December 2022. Poor surgical candidates were defined as patients who satisfied at least one of following criteria based on previous research15: aged ≥ 80 years, with an American Society of Anesthesiology Physical Status (ASA-PS) grade 3 or higher, Karnofsky Performance Status < 50, and/or age-adjusted Charlson Comorbidity Index (CCI) scores ≥ 516; however, the feasibility of surgical cholecystectomy (including elective cholecystectomy after improvement) was determined on the basis of discussion with surgeons at diagnosis. The exclusion criteria were age < 20 years, difficulty in conducting endoscopic procedures, presence of biliary stricture, concomitant biliary malignancy, and refusal to participate in the study.
The Institutional Review Board of Aichi Medical University Hospital approved this study, which was conducted in accordance with the principles of the Declaration of Helsinki (Approval Number: 2017-H129). All patients provided written informed consent before the procedure. The study protocol was registered with the University Hospital Medical Information Network Clinical Trial Registry database (identifier: UMIN000028074).
Devices
A dedicated 7-Fr catheter (Gadelius Medical, Tokyo, Japan), which fits a 0.025- or 0.035-inch guidewire, was used for lavage and aspiration (Fig. 1). The tip of the catheter is highly tapered to reduce the gap between the catheter and guidewire. Eight side holes with a diameter of 1 mm were created within a length of 25 mm from the tip, allowing aspiration and lavage with high flow.
A dedicated 7-Fr, single-pigtail, plastic stent (Hanako Medical, Saitama, Japan) was used for EGB-IS, which resembles a single pigtail on the gallbladder side and is straight on the bile duct side (Fig. 2). This stent can be used with both 0.025- and 0.035-inch guidewires, and the tip is highly tapered for good insertability. The stent length, which is the distance from the base of the pigtail part to the distal end, can be set to 90, 110, or 130 mm. A 90-mm long Nylon retrieval thread was attached to the distal end of the stent, so that the stent could be retrieved easily by pulling this thread.
Technique
A standard duodenoscope (Olympus Medical Systems, Tokyo, Japan) was inserted into the duodenum, followed by biliary cannulation. Choledocholithiasis, if present, was eliminated using a retrieval balloon and basket after endoscopic sphincterotomy. Otherwise, endoscopic sphincterotomy was not performed. Subsequently, guidewire insertion into the gallbladder was attempted via the cystic duct using a standard cannula and an angle-tip guidewire. If the access to the gallbladder was difficult, another angled-tip guidewire, swing-tip cannula-guided technique, and/or cholangioscopy-guided technique17,18 was employed. After the successful placement of the guidewire in the gallbladder, a dedicated catheter was inserted over the guidewire. After the guidewire was removed temporarily, bile was aspirated as much as possible, and lavage was performed meticulously with approximately 100 mL of saline. Finally, the guidewire was reinserted, followed by removal of the catheter. Subsequently, a dedicated 7-Fr, single-pigtail, stent was placed from the gallbladder to the bile duct. The thread was hung into the duodenum through the duodenal papilla (Fig. 3). The procedure was performed urgently (within 24 h). Elective stent exchange and removal were not performed.
When an AE occurred and the stent had to be removed, the distal end of the stent was pulled out into the duodenum by grasping and tugging at the thread using forceps. The stent was subsequently grasped using forceps and pulled and removed through the scope channel.
An endoscopist with experience in endoscopic retrograde cholangiography and EGBS conducted or directly supervised all procedures.
Follow-up
Blood tests were performed on the day after the procedure; computed tomography was performed, as appropriate, when AE was suspected. After achieving clinical success, patients underwent regular follow-up with or without abdominal radiography at least annually or semiannually. During this time, they were instructed to visit the hospital immediately if they experienced symptoms, including abdominal pain. Blood tests and imaging studies, such as ultrasonography and computed tomography, were performed upon suspicion of late AEs including recurrent cholecystitis.
Outcomes and definitions
The outcomes included technical success, clinical success, early AEs, cholecystitis recurrence, and other symptomatic late AEs associated with EGB-IS with lavage and aspiration. Technical success was defined as successful completion of biliary cannulation, advancement of the guidewire into the gallbladder, insertion of the dedicated catheter, appropriate lavage and aspiration, and stent placement above the papilla. Clinical success was defined as the resolution of clinical symptoms and laboratory findings associated with cholecystitis without the need for additional drainage procedures. The diagnosis and severity of cholecystitis and cholangitis were based on the Tokyo Guidelines 201819,20. Other AEs were defined and graded according to the criteria provided by the American Society for Gastrointestinal Endoscopy21.
Statistical analysis
The sample size was not calculated because this was a pilot investigation of a novel procedure using novel devices. Categorical variables were presented as numbers and percentages, and continuous variables were expressed as medians and interquartile ranges (IQR). The Kaplan–Meier method was used to estimate the cumulative incidence of the AEs. Patients’ data were censored if they did not experience any AE until the time of death, transfer to another institution, or the end of the study period. Additionally, if elective surgical cholecystectomy was performed after improvement of the general condition, the patient’s data were also censored at that time. All statistical analyses were conducted using EZR version 1.61 (Saitama Medical Center, Jichi Medical University, Saitama, Japan)22.
Results
Patient characteristics
Eighty-three patients who met the eligibility criteria were enrolled in this study. Table 1 presents the patients’ characteristics, including sex, age, age-adjusted CCI, ASA-PS classification, cause and severity of cholecystitis, number and diameter of the gallstones, and presence of choledocholithiasis. The median follow-up period was 603 (IQR 404–1314) days.
Procedural outcomes
Table 2 depicts the outcomes of EGB-IS with lavage and aspiration. The technical success rate was 80.7% (67/83). The reason for technical failure of all cases was difficulty in reaching the gallbladder through the cystic duct. The median quantity of bile aspirated was 60 (IQR 50–100) mL, and the median quantity of saline-aspirated lavage was 100 (IQR 100–100) mL. The median procedural time was 35 (IQR 27–48) min. The clinical success rate in patients in whom technical success was achieved was 98.5% (66/67) (Fig. 4). The frequency of early AEs was 3.6% (3/83). Moderate pancreatitis occurred in two patients, and mild post-endoscopic sphincterotomy bleeding occurred in one patient.
Long-term outcomes
The rate of incidence of recurrent cholecystitis was 4.5% (3/66), all instances of which were treated by removal of the stent using the thread and replacement with another stent. The rate of symptomatic late AEs, besides cholecystitis, was 6.1% (4/66). Cholangitis occurred in three patients, and liver abscess occurred in one patient. Cholangitis was treated by removal of the stent using the thread, followed by deployment of a bile duct stent. Liver abscess was treated with conservative management using antibiotics.
Twenty-three patients died for reasons unrelated to the procedure. The rate of overall late AEs (cholecystitis plus other events) was 10.6% (7/66). Kaplan–Meier analysis revealed that the 1-, 2-, and 3-year cumulative incidence rates of overall late AEs were 3.2%, 11.2%, and 18.9%, respectively (Fig. 5).
Discussion
This study demonstrated that the rate of recurrent cholecystitis and that of late AEs, other than cholecystitis, were low after EGB-IS with lavage and aspiration. Although the clinical success rate was good, the technical success rate was insufficient.
Prevention of recurrent cholecystitis in patients with calculous cholecystitis in whom cholecystectomy is contraindicated is an important issue in the treatment of cholecystitis23. The mechanisms by which long-term stent placement with EGBS prevents the recurrence of cholecystitis include the drainage effect within the stent, prevention of gallstone impaction by the stent, and straightening of the spiral structure of the cystic duct, which permits flow along the stent surface, even if the stent is occluded24. These mechanisms act in conjunction with each other to exert a preventive effect. Four comparative studies11,12,13,14 that investigated the long-term outcomes of EGBS reported that the rate of recurrent cholecystitis was 0–6.3%, which is significantly lower than that in patients who underwent percutaneous drainage (16.0–19.2%). On the other hand, the rate of late AEs, besides recurrent cholecystitis, i.e., mainly cholangitis, was reportedly high at 9.1–19.6%. A recent large-scale study14 indicated that the overall late AE rate (including cholecystitis plus other events) did not differ significantly between patients who underwent EGBS and those who underwent tube removal after PTGBD (25.9% vs. 30.0%, P = 0.500). Therefore, it is necessary to devise methods to reduce the frequency of other late AEs, mainly cholangitis, in order to optimize the preventive effect of EGBS against the recurrence of cholecystitis in poor surgical candidates. Retrograde infection due to duodenobiliary reflux, bacterial contamination, and cholestasis associated with the long-term presence of stents are thought to be the principal factors responsible for the onset of cholangitis14,25.
Sufficient lavage and aspiration can enhance the drainage effect and reduce the likelihood of stent occlusion, leading to better long-term outcomes, because infected bile is often viscous and turbid due to debris, which could also have contributed to the higher clinical success rate. Inside stenting can limit duodenobiliary reflux and adhesion of food residue to the distal end of the stent. Several studies on inside stenting for hilar biliary strictures have suggested that it results in significantly better long-term stent patency than that with stent placement across the papilla26,27,28. The present study is the first to investigate lavage and aspiration and the inside stent for gallbladder stenting: it found that the recurrence rate of cholecystitis was 4.5%, which is similar to previous reports of long-term stent placement via EGBS, and the rate of late AEs, other than cholecystitis, was 6.1%, which was lower than that reported in previous studies. Therefore, a certain effect may be expected when the inside stenting technique is employed for EGBS in conjunction with lavage and aspiration.
However, the low technical success rate is an important problem associated with EGBS. The bougie effect of the dedicated lavage catheter may also be effective in cases where passage of the stent through the cystic duct is difficult due to severe inflammation. However, the technical success rate in this study was 80.7%, which is approximately as insufficient as that reported in previous studies; thus, a sufficient additive effect of the catheter cannot be inferred. Guidewire selection for accessing the gallbladder through the cystic duct is a major factor responsible for failure of the procedure29. Therefore, even if the method described in this study improves long-term outcomes, an innovative maneuver that can improve the technical success rate is definitely required to ensure widespread application of EGBS as standard treatment in poor surgical candidates with calculous cholecystitis.
This study should be considered in the context of the limitations associated with its single-center setting, small sample size, and lack of a control cohort. Furthermore, the results may not be directly applicable to other institutions because all procedures were performed or supervised by a single endoscopist with experience in EGBS. Moreover, the AE rates could have been underestimated because the follow-up period may have been insufficient. The results of this study need to be confirmed by further clinical studies, including randomized controlled trials.
In conclusion, this is the first study to assess EGB-IS with lavage and aspiration for calculous cholecystitis in poor surgical candidates, with promising results, especially with respect to the long-term outcomes. This method may be a useful option when EGBS with long-term stent placement is planned, since the prevention of cholecystitis recurrence without an increase in the incidence of other AEs is anticipated.
Data availability
The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.
Abbreviations
- EGBS:
-
Endoscopic gallbladder stenting
- PTGBD:
-
Percutaneous transhepatic gallbladder drainage
- AE:
-
Adverse event
- EGB-IS:
-
Endoscopic gallbladder inside-stenting
- ASA-PS:
-
American Society of Anesthesiology Physical Status
- CCI:
-
Charlson comorbidity index
- IQR:
-
Interquartile range
References
Okamoto, K. et al. Tokyo guidelines 2018: flowchart for the management of acute cholecystitis [published correction appears in J Hepatobiliary Pancreat Sci. 2019 Nov;26(11):534]. J. Hepatobiliary Pancreat. Sci. 25(1), 55–72 (2018).
Mori, Y. et al. Tokyo guidelines 2018: Management strategies for gallbladder drainage in patients with acute cholecystitis (with videos). J. Hepatobiliary Pancreat. Sci. 25(1), 87–95 (2018).
McLoughlin, R. F., Patterson, E. J., Mathieson, J. R., Cooperberg, P. L. & MacFarlane, J. K. Radiologically guided percutaneous cholecystostomy for acute cholecystitis: Long-term outcome in 50 patients. Can. Assoc. Radiol. J. 45(6), 455–459 (1994).
Andrén-Sandberg, A., Haugsvedt, T., Larssen, T. B. & Søndenaa, K. Complications and late outcome following percutaneous drainage of the gallbladder in acute calculous cholecystitis. Dig. Surg. 18(5), 393–398 (2001).
Granlund, A., Karlson, B. M., Elvin, A. & Rasmussen, I. Ultrasound-guided percutaneous cholecystostomy in high-risk surgical patients. Langenbecks Arch. Surg. 386(3), 212–217 (2001).
Schlottmann, F., Gaber, C., Strassle, P. D., Patti, M. G. & Charles, A. G. Cholecystectomy vs. cholecystostomy for the management of acute cholecystitis in elderly patients. J. Gastrointest. Surg. 23(3), 503–509 (2019).
Markopoulos, G. et al. Outcomes of percutaneous cholecystostomy in elderly patients: A systematic review and meta-analysis. Prz. Gastroenterol. 16(3), 188–195 (2021).
Mora-Guzmán, I. et al. Conservative management of gallstone disease in the elderly population: Outcomes and recurrence. Scand. J. Surg. 109(3), 205–210 (2020).
Winbladh, A., Gullstrand, P., Svanvik, J. & Sandström, P. Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford) 11(3), 183–193 (2009).
Ramírez-Giraldo, C., Isaza-Restrepo, A., Rico-Rivera, E. X., Vallejo-Soto, J. C. & Van-Londoño, I. Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute calculous cholecystitis in patients over 90 years of age. Langenbecks Arch. Surg. 408(1), 194 (2023).
Kedia, P. et al. Endoscopic gallbladder drainage compared with percutaneous drainage. Gastrointest. Endosc. 82(6), 1031–1036 (2015).
Inoue, T. et al. Long-term outcomes of endoscopic gallbladder stenting in high-risk surgical patients with calculous cholecystitis (with videos). Gastrointest. Endosc. 83(5), 905–913 (2016).
Maruta, A. et al. Permanent endoscopic gallbladder stenting versus removal of gallbladder drainage, long-term outcomes after management of acute cholecystitis in high-risk surgical patients for cholecystectomy: Multi-center retrospective cohort study. J. Hepatobiliary Pancreat. Sci. 28(12), 1138–1146 (2021).
Inoue, T. et al. Long-term impact of endoscopic gallbladder stenting for calculous cholecystitis in poor surgical candidates: A multi-center comparative study. Dig. Dis. Sci. https://doi.org/10.1007/s10620-022-07651-0 (2022).
Teoh, A. Y. B. et al. Endoscopic ultrasound-guided gallbladder drainage reduces adverse events compared with percutaneous cholecystostomy in patients who are unfit for cholecystectomy. Endoscopy 49(2), 130–138 (2017).
Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 40(5), 373–383 (1987).
Ridtitid, W. et al. Single-operator peroral cholangioscopy cystic duct cannulation for transpapillary gallbladder stent placement in patients with acute cholecystitis at moderate to high surgical risk (with videos). Gastrointest. Endosc. 92(3), 634–644 (2020).
Yoshida, M. et al. Four-step classification of endoscopic transpapillary gallbladder drainage and the practical efficacy of cholangioscopic assistance. Gut Liver 15(3), 476–485 (2021).
Yokoe, M. et al. Tokyo guidelines 2018: Diagnostic criteria and severity grading of acute cholecystitis (with videos). J. Hepatobiliary Pancreat. Sci. 25(1), 41–54 (2018).
Kiriyama, S. et al. Tokyo guidelines 2018: Diagnostic criteria and severity grading of acute cholangitis (with videos). J. Hepatobiliary Pancreat. Sci. 25(1), 17–30 (2018).
Cotton, P. B. et al. A lexicon for endoscopic adverse events: Report of an ASGE workshop. Gastrointest. Endosc. 71(3), 446–454 (2010).
Kanda, Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48, 452–458 (2013).
Inoue, T. et al. Long-term outcomes of endoscopic gallbladder drainage for cholecystitis in poor surgical candidates: An updated comprehensive review. J. Clin. Med. 10(21), 4842 (2021).
Elmunzer, B. J., Novelli, P. M., Taylor, J. R., Piraka, C. R. & Shields, J. J. Percutaneous cholecystostomy as a bridge to definitive endoscopic gallbladder stent placement. Clin. Gastroenterol. Hepatol. 9(1), 18–20 (2011).
Maekawa, S. et al. Endoscopic gallbladder stenting for acute cholecystitis: A retrospective study of 46 elderly patients aged 65 years or older. BMC Gastroenterol. 13, 65 (2013).
Kobayashi, N. et al. Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol. 15, 8 (2015).
Kurita, A. et al. Stent placement above the sphincter of Oddi is a useful option for patients with inoperable malignant hilar biliary obstruction. Surg. Endosc. 36(5), 2869–2878 (2022).
Kogure, H. et al. A prospective multicenter study of “inside stents” for biliary stricture: Multicenter evolving inside stent registry (MEISteR). J. Clin. Med. 10(13), 2936 (2021).
Maruta, A. et al. Factors affecting technical success of endoscopic transpapillary gallbladder drainage for acute cholecystitis. J. Hepatobiliary Pancreat. Sci. 27(7), 429–436 (2020).
Author information
Authors and Affiliations
Contributions
T.I. conception and design, data acquisition, analysis and interpretation, and drafting and revision of the manuscript. R.K. data acquisition and interpretation, and revision of the manuscript. M.I., Y.K., K.I., and M.Y. data interpretation, and revision of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Inoue, T., Kitano, R., Ibusuki, M. et al. Endoscopic gallbladder inside-stenting combined with aspirated lavage for calculous cholecystitis in poor surgical candidates: a prospective pilot study. Sci Rep 13, 21156 (2023). https://doi.org/10.1038/s41598-023-48543-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-48543-1
- Springer Nature Limited